Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Late last month, I noted that the overturning of Chevron did not mean the end of judicial deference to agency expertise. Earlier this week, a decision by the D.C. Circuit Court of Appeals provided some confirmation that...more